Figure 2.
Monthly rate of use of unfractionated heparin, enoxaparin and fondaparinux in the whole population and by type of center (A: University center with cath lab facilities on site, B: community centers with cath lab on site, C: community centers without cath lab on site). Reproduced with permission from Schiele F, Meneveau N, Seronde MF, et al. Routine use of fondaparinux in acute coronary syndromes: a 2-year multicenter experience. Am Heart J. 2010;159(2):190–198.20 Copyright © 2010 Elsevier.